Montreal, Canada, is making significant strides in the life sciences sector. It’s home to a growing number of standout biotech firms specializing in areas like artificial intelligence, protein therapeutics, immunotherapies, and more. Nine of these companies, including Ability Biotherapeutics, Congruence Therapeutics, and Cura Therapeutics, have recently made notable advancements in their research, securing substantial seed funding and making progress on developing treatments for various illnesses, ranging from cancer and autoimmune diseases to rare genetic disorders and COVID-19.
Why True Healthcare Interoperability Needs AI
Consensus Cloud Solutions’ Johnny Hecker suggests that achieving interoperability in healthcare should involve artificial intelligence (AI) to lower costs for smaller organizations. Rather than implementing
